Successful treatment with tandem consolidation using 90yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 47; no. 6; pp. 877 - 879
Main Authors Han, E J, Yang, S-A, Sohn, H-S, Kim, J I, Kang, C-S, Cho, S-G
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2012
Nature Publishing Group
Subjects
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Antibodies, Monoclonal - administration & dosage
Biological and medical sciences
Bone marrow
Bone marrow, stem cells transplantation. Graft versus host reaction
Cell Biology
Hematologic and hematopoietic diseases
Hematology
Humans
Internal Medicine
Intestinal Polyposis - pathology
Intestinal Polyposis - therapy
letter-to-the-editor
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma
Lymphoma, Mantle-Cell - pathology
Lymphoma, Mantle-Cell - therapy
Mantle cell lymphoma
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Peripheral Blood Stem Cell Transplantation
Polyposis
Public Health
Stem cell transplantation
Stem Cells
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation, Autologous
Antineoplastic agent
Human
Relapse
Hematology
Stem cell
Ibritumomab tiuxetan
B cell neoplasm
Malignant hemopathy
B-Lymphocyte
Monoclonal antibody
Non Hodgkin lymphoma
Polyposis
Consolidation treatment
Immunomodulator
Lymphoproliferative syndrome
Mantle cell lymphoma
Graft
High dose
Cancer
Online AccessGet full text

Cover

More Information
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2011.193